Les meilleurs doctors en en Israël - TOP-21 des médecins

Plus de 300 greffes pédiatriques de moelle osseuse et de sang de cordon effectuées – Le Dr El Hasid dirige le département d'onco-hématologie pédiatrique de l'hôpital pour enfants Dana Dwek.

• Spécialisé exclusivement dans les cas de greffes pédiatriques
• A publié plus de 50 articles et 40 rapports de conférence sur l'oncologie pédiatrique
• Membre de l'American Association for Hematology et de la Société Israélienne d'Hémato-Oncologie Pédiatrique
• Formé au City of Hope Hospital à Los Angeles

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Le professeur Shlomi Constantini est un neurochirurgien pédiatrique de premier plan au centre médical Sourasky, spécialisé dans les tumeurs du cerveau et de la moelle épinière chez l'enfant.

• Formé à la microneurochirurgie et à la neuro-endoscopie avancée à travers l'Europe
• Expert en troubles congénitaux et néonataux de la structure osseuse
• Lauréat du Mahaly Best Clinical Research Award de l'AANS
• Membre actif de plusieurs sociétés internationales de neurochirurgie

Le Dr Dror Levin dirige l'unité d'hémato-oncologie pédiatrique d'Israël au Sourasky Medical Center, spécialisé dans les sarcomes de l'enfant et les troubles sanguins.

• Formé à l'Institut Orthopédique Rizzoli – un leader mondial du cancer des os
• Coordonne les soins multidisciplinaires des sarcomes avec les équipes d'oncologie orthopédique
• Membre de la Société Israélienne d'Hémato-Oncologie Pédiatrique (ISPHO)
• Spécialisé dans les cancers pédiatriques rares et les troubles de la coagulation sanguine

Classé par Forbes parmi les meilleurs médecins d'Israël – Le Dr Goldstein dirige le département d'oncologie pédiatrique du centre médical Hadassah.

• Plus de 20 ans de spécialisation en hémato-oncologie pédiatrique
• Expert en transplantation haplo-identique de moelle osseuse pour les enfants
• Se concentre sur le rétinoblastome et la médecine de précision dans le cancer pédiatrique
• Membre de la Société Internationale d'Oncologie Pédiatrique (SIOP)

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Le Dr Auala Hubert dirige le centre des cancers gastro-intestinaux du centre médical Hadassah, avec plus de 33 ans d'expérience en oncologie et en radiothérapie.

• Spécialisé en oncologie pédiatrique avec un accent sur les cancers gastro-intestinaux
• Certifié en oncologie et en radiothérapie
• Membre de l'Israel Society of Clinical Oncology et de l'Israel Cancer Association
• Formé à l'hôpital universitaire Hadassah, l'un des meilleurs centres médicaux d'Israël

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Boaz Liberman, MD, is an orthopedic oncologist and sarcoma surgeon for adults and children. He directs the Orthopedic Oncology Unit and serves as Vice Head of Orthopedic Surgery at Sheba Medical Center. His focus is limb-sparing cancer surgery with functional reconstruction. He performs complex joint reconstruction, revision arthroplasty, MRgFUS, and reconstruction after bone metastases.

Education and training: MD, Tel Aviv University. Orthopedic surgery residency, Sheba Medical Center. Fellowships in Adult Reconstruction at Mount Sinai Hospital, Toronto, and in Orthopedic Oncology at Mount Sinai Hospital and Princess Margaret Cancer Centre. He is board-certified in Orthopedic Surgery and in Orthopedic Oncology Surgery. He is a Clinical Instructor at Tel Aviv University. Memberships include the Israel Medical Association, Israel Orthopedic Association, AATB, and EATB. He also serves on national advisory committees. His research covers bone and soft tissue sarcomas, serum markers, imaging-guided therapies, MRI arthrography, and the biomechanics of bone treated with MRgFUS.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD

Global Leader in Pediatric Hemato-Oncology, CAR-T Therapy & Bone Marrow Transplantation

About Prof. Elad Jacoby

Prof. Elad Jacoby is one of the world’s leading experts in pediatric hemato-oncology and advanced cellular therapies, serving as the Head of the Pediatric Cell Therapy Center and Medical Director of the Advanced Biotherapy Center at Sheba Medical Center. With nearly two decades of clinical and research experience, he is widely recognized for transforming the treatment landscape for children with complex and treatment-resistant blood cancers.

Prof. Jacoby is a pioneer of CAR-T cell therapy in Israel, having led the implementation of one of the first national programs for pediatric leukemia. His work focuses on delivering highly personalized, cutting-edge therapies to children who often have limited or no remaining standard treatment options.

Beyond his clinical leadership, he is an Associate Professor at Tel Aviv University, actively involved in training the next generation of physicians while leading groundbreaking international research in immunotherapy and cellular medicine.

Clinical Expertise & Special Focus

Prof. Jacoby specializes in the most advanced and life-saving treatments for children and young patients with hematologic malignancies, including:

• CAR-T Cell Therapy (Chimeric Antigen Receptor T-Cells)
  Personalized immunotherapy designed to reprogram the patient’s immune system to fight cancer
• Bone Marrow & Stem Cell Transplantation (BMT)
  Including complex and high-risk transplant cases
• Pediatric Leukemia & Lymphoma
  Acute lymphoblastic leukemia (ALL), relapsed/refractory leukemias, and aggressive lymphomas
• Advanced Cellular Immunotherapy
  Including anti-viral T-cell therapies for immunocompromised patients
• Mitochondrial Augmentation Therapy (MAT)
  First-in-human innovative treatments for rare and complex conditions

His approach combines precision medicine, immunotherapy, and transplantation, allowing for comprehensive, individualized care even in the most challenging cases.

Innovation & Research Leadership

Prof. Jacoby is at the forefront of global innovation in pediatric cancer care. He leads and participates in international clinical trials focused on next-generation therapies, including:

• CAR-T therapies for resistant leukemias and lymphomas
• Novel cellular therapies targeting cancer and severe infections
• Breakthrough research in mitochondrial medicine and immune system modulation

He has authored over 240 scientific publications in leading medical journals and collaborates with top institutions worldwide, including:

• Johns Hopkins Hospital (USA)
• National Cancer Institute (NCI), USA
• International pediatric oncology and CAR-T research networks

His research directly translates into real-world treatment options, giving patients access to therapies not widely available elsewhere.

Patient-Centered Approach

Prof. Jacoby is known not only for his clinical excellence but also for his deep commitment to patient-centered care. Every child and family receives:

• A fully personalized treatment plan tailored to the disease and patient profile
• Access to the most advanced therapies available globally
• Close monitoring by a multidisciplinary team of experts
• Compassionate guidance throughout every stage of treatment

His philosophy is simple: combine innovation with empathy, ensuring that families feel supported, informed, and confident in their care journey.

Leadership & Roles

• Head, Pediatric Cell Therapy Center, Sheba Medical Center
• Medical Director, Advanced Biotherapy Center, Sheba Medical Center
• Senior Lecturer / Associate Professor, Tel Aviv University School of Medicine
• Member, CAR-T Cell Taskforce (IBFM Study Group)
• Member, Institutional Review Board, Sheba Medical Center

Education & International Training

• MD, Tel Aviv University School of Medicine
• Pediatrics Residency, Sheba Medical Center
• Fellowship in Pediatric Hematology & Oncology, Johns Hopkins Hospital, USA
• Clinical & Research Fellowship, National Cancer Institute (NCI), USA

Board Certifications

• Pediatrics
• Pediatric Hematology & Oncology

Why Patients Choose Prof. Elad Jacoby

• Pioneer of pediatric CAR-T therapy in Israel
• Leader in integrating CAR-T with bone marrow transplantation
• Access to exclusive clinical trials and next-generation treatments
• Extensive experience in complex and relapsed cases
• Internationally recognized expert with a strong academic and research background
• Dedicated to delivering hope through innovation and personalized care

A Leader in the Future of Pediatric Cancer Care

Through his work, Prof. Jacoby continues to redefine what is possible in treating childhood cancers—bringing together science, innovation, and compassionate care to improve outcomes and give new hope to patients and their families worldwide.

Le Dr Hodaya Cohen est une obstétricienne-gynécologue certifiée au centre médical Hadassah, spécialisée dans la santé des femmes.

• Très expérimentée dans la gestion de tous les aspects de la santé des femmes
• Fournit des soins complets et compatissants
• Exerce au prestigieux centre médical Hadassah

Le Dr Irina Zaidman est spécialisée dans les greffes de moelle osseuse pédiatriques au centre médical Hadassah, avec des spécialisations à Toronto et à Rambam.

• Membre du conseil d'administration de la Société israélienne d'hémato-oncologie pédiatrique
• Membre des sociétés européenne et américaine de BMT
• A publié de nombreux articles sur la BMT pédiatrique
• Active dans l'enseignement de l'hématologie-oncologie pédiatrique

Le Dr Jose Cohen apporte plus de 15 ans d'expertise en oncologie pédiatrique au centre médical Hadassah, en se concentrant sur des traitements innovants.

• MBBS de l'Université de Londres, Royaume-Uni
• Membre de l'International Cardio-Oncology Society
• Lauréat du Healthcare Manpower Development Plan (HMDP, 2017)
• A publié divers articles en oncologie
• Parle couramment l'anglais et le malais

Plus de 3 500 greffes de moelle osseuse réalisées – le Dr Stepensky est reconnu par Forbes comme l'un des meilleurs médecins en oncologie pédiatrique.

• Plus de 20 ans d'expérience en oncologie pédiatrique
• Spécialisé dans le traitement des maladies rares du cancer du sang chez les enfants
• Connu par les patients comme celui qui « transplante la vie »
• Travaille au centre médical Hadassah

Reconnu internationalement en oncologie pédiatrique, le Pr Ben-Harush a été nommé l'un des médecins les plus attentionnés au monde par l'Association médicale mondiale.

• Directeur de la division pédiatrique à l'hôpital pour enfants Ruth Rappaport
• Spécialisé en oncologie pédiatrique et en transplantation de moelle osseuse
• Décoré du Chevalier de la Légion d'Honneur en France
• Membre de groupes d'oncologie pédiatrique aux États-Unis et en Europe

Le Dr Gutman est spécialisé dans le traitement des cas de cancer complexes, avec un accent sur les cancers rares au centre médical Assuta.

• Spécialisé en oncologie chirurgicale avec une expertise dans les tumeurs rares et difficiles
• Travaille au centre médical Assuta, un établissement de premier plan pour le traitement oncologique
• Dédié à la gestion des cas complexes nécessitant une intervention chirurgicale